OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Indexing: DOAJ-Directory of Open Access Journals.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 7.5 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period).
New Developments in Brain Injury
Submission Deadline: August 31, 2020 (Open)
Lynne Ann Barker, PhD Reader in Cognitive Neuroscience
Department of Psychology, Sociology and Politics, Sheffield Hallam University, Sheffield, United Kingdom
Website | E-Mail
Research Interests: Neuropsychology; Cognitive Neuroscience; Brain Trauma; Cognitive assessment; Biomarkers of Neuropathology, Novel Interventions and Therapeutics
About This Topic
Estimates of incidence of brain injury across the globe vary considerably, but it is clear that brain injury remains a major cause of death and disability, particularly in youth. Advances in critical care mean that most have normal life expectancy but quality of life is frequently, sometimes devastatingly, compromised. There is an urgent need for new approaches, interventions, therapies, treatments and diagnostic tools that better assess real world capacity and draw on new technologies and advances in science. One particular topic of interest is inconsistency around severity diagnosis (e.g. when to start measuring PTA and GCS, particularly if someone is in a coma or the injury is mild in nature,) and the impact this has on brain injury statistics and rehabilitation. It is a critical priority to develop new ways of standardizing this process. In this special edition we invite submissions that specifically embrace this new spirit of innovation in brain injury assessment, treatment and research. Our aim is to showcase new, inventive and original approaches to longstanding issues in brain injury research and neurorehabilitation.
Manuscripts should be submitted online at http://www.lidsen.com/account-login by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. Guidelines for authors and other relevant information for submission of manuscripts are available on the Instructions for Authors page. OBM Neurobiology is an international peer-reviewed Open Access monthly journal published by LIDSEN. Please visit the Instructions for Authors page before submitting a manuscript.
Title: Role of Erythropoietin in Brain Injury
Authors: Stephana Carelli , Michele Samaja
Affiliation: Department of Health Science, University of Milan, Italy
Abstract: Erythropoietin (EPO), widely known as an erythropoietic hormone, is recognized as a protective messenger in several biological systems, including the cerebrovascular. A downstream protein whose synthesis is triggered by hypoxia-related stresses, EPO exerts its anti-apoptotic and anti-inflammatory effects through its receptor and the activation of the STAT3 pathways, as demonstrated especially in traumatic spinal cord injury. However, it appears that EPO may be related to non-hypoxia-related pathways, such as in Parkinson’s disease, and that hyperoxia, a condition opposite to hypoxia, may be as deleterious as hypoxia in generating brain injury. We will review these mechanisms, evaluating also the potential use of EPO mimics as potential therapeutic targets.
Title: Matrix metalloproteinases in central nervous system development and repair
Authors: Holly Colognato
Affiliation: Department of Pharmacology, Stony Brook University, Stony Brook, NY 11794-8651, USA
Title: Analysis of 16 Coils Over 50 MRI-derived Head Models in Transcranial Magnetic Stimulation
Authors: Philippe simon
Affiliation: Recherche clinique, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
Ryan Sweeney, Alvaro J La Rosa, Nina Sheade, Rachael C. Olson-Marszewski, Ryan Bergren, Edwin Meresh
Received: January 12, 2020; Published: April 01, 2020; doi:10.21926/obm.neurobiol.2002054
Edwin Meresh, David Daniels, Jack H. Owens, David Thompson, Sarah Mennella, Michael Levy, Brenda Swartz
Received: November 10, 2019; Published: January 10, 2020; doi:10.21926/obm.neurobiol.2001048
Alan J Pearce
Received: July 05, 2019; Published: September 27, 2019; doi:10.21926/obm.neurobiol.1903042
Rastislav Burda, Viera Danielisová, Jozef Burda
Received: July 03, 2019; Published: September 20, 2019; doi:10.21926/obm.neurobiol.1903041
Katherine Satrom, Tate Gisslen, Raghavendra Rao
Received: May 29, 2019; Published: August 29, 2019; doi:10.21926/obm.neurobiol.1903038
Berta Monleón López, Valentina Della Torre, Federico Bilotta, Rafael Badenes
Received: June 11, 2019; Published: August 22, 2019; doi:10.21926/obm.neurobiol.1903037
Hideki Kanamaru, Fumihiro Kawakita, Reona Asada, Hidenori Suzuki
Received: May 07, 2019; Published: July 29, 2019; doi:10.21926/obm.neurobiol.1903035